Protein Kinase Inhibitors
The Promise of Natural Products in Cancer Therapeutics
-
20% KEDVEZMÉNY?
- A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
- Kiadói listaár EUR 162.99
-
63 663 Ft (60 632 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 20% (cc. 12 733 Ft off)
- Kedvezményes ár 50 931 Ft (48 506 Ft + 5% áfa)
- A kedvezmény érvényes eddig: 2026. június 30.
Iratkozzon fel most és részesüljön kedvezőbb árainkból!
Feliratkozom
63 663 Ft
Beszerezhetőség
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadó Elsevier Science
- Megjelenés dátuma 2026. szeptember 1.
- ISBN 9780443275449
- Kötéstípus Puhakötés
- Terjedelem500 oldal
- Méret 235x191 mm
- Súly 450 g
- Nyelv angol 0
Kategóriák
Hosszú leírás:
Protein Kinase Inhibitors: The Promise of Natural Products in Cancer Therapeutics explores a novel therapeutic avenue for cancer treatment through nutraceutical-based kinase inhibitors. The book covers their historical background, outlook, mechanistic pathways, and clinical aspects, highlighting their relevance in cancer therapy. It also examines the potential of polyphenolic derivatives and other natural compounds in inhibiting key kinases involved in major cancer signaling pathways, focusing on their application in clinical trials and marketed drugs. Sections explore the implications of polyphenols in cancer management, novel sources of breast cancer inhibitors, the role of natural products in lymphoma therapy, and the multitarget potential of phytochemicals.
Each chapter is designed to provide a thorough understanding of how natural products can be harnessed to develop innovative cancer therapeutics. It will serve as a valuable resource for academics, scientists, young researchers, students, and pharmacists working or interested in kinase biology and cancer therapeutics with its unique perspective on using nature's own arsenal to combat cancer.
Tartalomjegyzék:
1. Nutraceuticals: From History to Modern Outlook
2. Implications of Polyphenols in Cancer Management
3. Revealing Novel Sources of Breast Cancer Inhibitors
4. A Promising Natural Product in Diffuse Large B-Cell Lymphoma Therapy
5. Inhibiting Inflammation via IL-17/NF-?B Pathway
6. Mechanistic Pathways and Clinical Aspects of Natural CDK Inhibitors on Cancer Progression
7. Natural Kinase Inhibitors in Lymphoma Therapy
8. Natural Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma
9. Identification of Marine Natural Products as STAT3 Inhibitors for Efficient Anticancer Therapy
10. Multitarget Potential of Phytochemicals
11. Naturally Occurring Compounds as Potential Inhibitors of Epidermal Growth Factor Receptors
12. Exploring Potential Phytochemicals for Hepatocellular Carcinoma
13. The Natural Product in Resistant Lung Cancer
14. Anticancer Potential of Novel Natural Product Derivatives Targeting the PI3K/AKT Signaling Pathway
15. Plant-Based mTOR Inhibitors for Cancer Therapy
16. Role of Nutraceuticals in Combating Oxidative Stress via Modulating MAPK Signalling
17. Epigenetic Effects of SCFAs: Butyrate’s Effects on Spleen Tyrosine Kinase (Syk) in Tumor Progression
18. Exploring Chemopreventive Effects of Olive Products Attenuating Cancer Signaling
19. Confronting Overexpressed Tyrosine Kinases with Curcumin: Advancing Adjuvant Cancer Therapies
20. Medicinal Benefits of Polyphenols in Cancer Prevention and Therapy through Suppression of PI3K Pathway
21. Structural Biology-Based Design of Selective Protein Kinase Inhibitors
22. Identifying Novel Cyclin-Dependent Kinase Attenuators Based on High Throughput Screening
23. Exploring the Potential of Pseudosaccharine Derivatives as Anti-Proliferative Agents and Kinase Inhibitors
24. Integrating Structure-Based Modeling and Advanced MD Simulation Strategy in Revealing the Potency of Natural Products as Dual Kinase Inhibitors
25. Discovering Novel Kinase Inhibitors: Moving from Structure to Clinical Leads
